Your session is about to expire
← Back to Search
Personalized Nutrition Intervention for Gestational Diabetes (DESI-GDM Trial)
DESI-GDM Trial Summary
This trial will assess the impact of a culturally tailored, personalized nutrition intervention on glycemic response to an oral glucose load in high-risk pregnancies of South Asian women.
DESI-GDM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.DESI-GDM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I often feel very nauseous or vomit a lot.I am not willing to change my diet.You are pregnant with only one baby.You have a higher chance of having complications during pregnancy, like having twins, using fertility treatments, or having certain health conditions.I am over 29, have a poor diet, a family history of diabetes, had gestational diabetes, or my BMI is over 23.17.You are currently pregnant and have ancestors from South Asia.Your blood pressure is higher than 140 over 90.I have diabetes.I am not willing to walk.You are in weeks 12 to 18 of pregnancy.
- Group 1: Dietary Intervention
- Group 2: Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you please clarify if this research is recruiting participants?
"This clinical trial is presently recruiting participants. Its listing on clinicaltrials.gov dates back to November 26th 2020, with the most recent edit occurring on April 28th 2022."
What is the primary aim of this experiment?
"In the span of three months, this experiment will assess completion rate as its primary purpose and delving into gestational diabetes mellitus, birthweight, and sum-of-skinfolds as secondary outcomes. Gestational diabetes is classified through fasting glucose levels that exceed 5.2 mmol/L or 2 hour post-load level exceeding 7.2 mmol/L; birthweights are measured to the nearest 10g with a digital weight scale while sum-of skin folds are determined by measuring to the nearest 0.2 mm with calipers in order to evaluate body density, fat content and FFM (fat free mass)."
How many individuals are participating in this research endeavor?
"Affirmative. According to details hosted on clinicaltrials.gov, this experiment is currently recruiting applicants and was first published on November 26th 2020 with most recent updates from April 28th 2022. The number of patients needed for the trial stands at 190 in two distinct medical centres."
Share this study with friends
Copy Link
Messenger